Health Care & Life Sciences » Pharmaceuticals | Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.04
Market Cap
$982.72 M
Shares Outstanding
47.07 M
Public Float
34.04 M

Profile

Address
11570 6th Street
Rancho Cucamonga California 91730
United States
Employees -
Website http://www.amphastar.com
Updated 07/08/2019
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs.

Financials

View All
Created with Highcharts 5.0.14Amphastar Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.11 86211 86210 69910 6992 7872 78710 53210 5324 5084 5085 7385 73820132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Amphastar Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.229 681229 681210 461210 461251 519251 519255 165255 165240 175240 175294 666294 666201320142015201620172018050k100k150k200k250k300k350k

Zi Ping Luo
Chairman, COO & Chief Scientist
Jason B. Shandell
President, Director & General Counsel